Biopsy-proven FSGS recurrence and clinical course of the study patients (sensitivity analysis).
| . | All patients (n = 66) . | PT– (n = 26) . | PT+ (n = 40) . | P-value . |
|---|---|---|---|---|
| Biopsy-proven FSGS recurrence | 29 (43.9) | 11 (42.3) | 18 (45.0) | .80 |
| Time to recurrence (days) (n = 29) | 5 (1; 130) | 74 (15; 335) | 2 (1; 8) | .02 |
| Proteinuria at recurrence (g/day or UCPR) (n = 29) | 3.0 (2.2; 4.7) | 3.2 (2.0; 7.0) | 3.0 (2.4; 4.4) | .91 |
| Serum albumin at recurrence (g/dL) (n = 18) | 31 (27; 39) | 31 (27;39) | 31 (27;38) | .38 |
| Partial remission | 24/29 (82.8) | 10/11 (90.9) | 14/18 (77.8) | .38 |
| Time to partial remission (days) (n = 22) | 15 (3; 35) | 20 (11; 62) | 11 (1; 28) | .29 |
| Complete remission | 16/29 (55.2) | 6/11 (54.5) | 10/18 (55.6) | .96 |
| Time to complete remission (days) (n = 15) | 37 (18; 137) | 44 (18; 54) | 35 (18; 137) | .81 |
| . | All patients (n = 66) . | PT– (n = 26) . | PT+ (n = 40) . | P-value . |
|---|---|---|---|---|
| Biopsy-proven FSGS recurrence | 29 (43.9) | 11 (42.3) | 18 (45.0) | .80 |
| Time to recurrence (days) (n = 29) | 5 (1; 130) | 74 (15; 335) | 2 (1; 8) | .02 |
| Proteinuria at recurrence (g/day or UCPR) (n = 29) | 3.0 (2.2; 4.7) | 3.2 (2.0; 7.0) | 3.0 (2.4; 4.4) | .91 |
| Serum albumin at recurrence (g/dL) (n = 18) | 31 (27; 39) | 31 (27;39) | 31 (27;38) | .38 |
| Partial remission | 24/29 (82.8) | 10/11 (90.9) | 14/18 (77.8) | .38 |
| Time to partial remission (days) (n = 22) | 15 (3; 35) | 20 (11; 62) | 11 (1; 28) | .29 |
| Complete remission | 16/29 (55.2) | 6/11 (54.5) | 10/18 (55.6) | .96 |
| Time to complete remission (days) (n = 15) | 37 (18; 137) | 44 (18; 54) | 35 (18; 137) | .81 |
Data are presented as the number of patients (percentages) or median (25th; 75th percentiles). In the first column, ‘n’ is the number of available data when the analyses are not performed on the whole sample (n = 66).
Biopsy-proven FSGS recurrence and clinical course of the study patients (sensitivity analysis).
| . | All patients (n = 66) . | PT– (n = 26) . | PT+ (n = 40) . | P-value . |
|---|---|---|---|---|
| Biopsy-proven FSGS recurrence | 29 (43.9) | 11 (42.3) | 18 (45.0) | .80 |
| Time to recurrence (days) (n = 29) | 5 (1; 130) | 74 (15; 335) | 2 (1; 8) | .02 |
| Proteinuria at recurrence (g/day or UCPR) (n = 29) | 3.0 (2.2; 4.7) | 3.2 (2.0; 7.0) | 3.0 (2.4; 4.4) | .91 |
| Serum albumin at recurrence (g/dL) (n = 18) | 31 (27; 39) | 31 (27;39) | 31 (27;38) | .38 |
| Partial remission | 24/29 (82.8) | 10/11 (90.9) | 14/18 (77.8) | .38 |
| Time to partial remission (days) (n = 22) | 15 (3; 35) | 20 (11; 62) | 11 (1; 28) | .29 |
| Complete remission | 16/29 (55.2) | 6/11 (54.5) | 10/18 (55.6) | .96 |
| Time to complete remission (days) (n = 15) | 37 (18; 137) | 44 (18; 54) | 35 (18; 137) | .81 |
| . | All patients (n = 66) . | PT– (n = 26) . | PT+ (n = 40) . | P-value . |
|---|---|---|---|---|
| Biopsy-proven FSGS recurrence | 29 (43.9) | 11 (42.3) | 18 (45.0) | .80 |
| Time to recurrence (days) (n = 29) | 5 (1; 130) | 74 (15; 335) | 2 (1; 8) | .02 |
| Proteinuria at recurrence (g/day or UCPR) (n = 29) | 3.0 (2.2; 4.7) | 3.2 (2.0; 7.0) | 3.0 (2.4; 4.4) | .91 |
| Serum albumin at recurrence (g/dL) (n = 18) | 31 (27; 39) | 31 (27;39) | 31 (27;38) | .38 |
| Partial remission | 24/29 (82.8) | 10/11 (90.9) | 14/18 (77.8) | .38 |
| Time to partial remission (days) (n = 22) | 15 (3; 35) | 20 (11; 62) | 11 (1; 28) | .29 |
| Complete remission | 16/29 (55.2) | 6/11 (54.5) | 10/18 (55.6) | .96 |
| Time to complete remission (days) (n = 15) | 37 (18; 137) | 44 (18; 54) | 35 (18; 137) | .81 |
Data are presented as the number of patients (percentages) or median (25th; 75th percentiles). In the first column, ‘n’ is the number of available data when the analyses are not performed on the whole sample (n = 66).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
